MBX Biosciences, Inc. MBX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s change in AP?
- MBX Biosciences, Inc. (MBX) reported change in AP of $3.97M in Q1 2026.
- How has MBX Biosciences, Inc.'s change in AP changed year-over-year?
- MBX Biosciences, Inc.'s change in AP increased by 354.0% year-over-year, from -$1.56M to $3.97M.
- What is the long-term trend for MBX Biosciences, Inc.'s change in AP?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s change in AP has grown at a 144.2% compound annual growth rate (CAGR), from $412K to -$2.46M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.